Human NGFR (nerve growth factor receptor) lentiviral particles are genetically engineered viral vectors designed to efficiently deliver the NGFR gene to target cells. These particles are derived from the lentiviral family, known for their ability to integrate into both dividing and non-dividing cells, ensuring long-term, stable gene expression. The NGFR gene encodes the p75 neurotrophic factor receptor, which plays a key role in neuronal development, survival, and signaling. Lentiviral particles are pseudotyped with the vesicular stomatitis virus glycoprotein (VSV-G), broadening their tropism and increasing transduction efficiency in a variety of mammalian cell types.
Human NGFR lentiviral particles are widely used in neuroscience research, regenerative medicine, and cell therapy. In neuroscience, they are a powerful tool for studying the role of NGFR in neuronal differentiation, apoptosis, and neurodegenerative diseases such as Alzheimer''s and Parkinson''s diseases. By transducing neural stem cells or primary neurons, researchers can investigate NGFR-mediated signaling pathways and their impact on cell behavior. In the field of regenerative medicine, these particles are used to engineer stem or progenitor cells for tissue repair, particularly in models of neural injury. Furthermore, NGFR lentiviral particles are used in chimeric antigen receptor (CAR) T-cell therapies, where NGFR serves as a selection marker or safety switch to monitor and control engineered immune cells. Their versatility also extends to in vivo studies, enabling targeted gene delivery in animal models to explore therapeutic interventions.
Gene transfer to airway epithelial cells is hampered by extracellular (mainly mucus) and cellular (tight junction) barriers. Magnetoresis has been used to increase the residence time of lentiviral vectors (LV) on the cell surface. In this study, magnetoresis was investigated in an airway epithelial cell model that mimics extracellular and cellular barriers. LV-mediated transduction was assessed after polarization of bronchial epithelial cells (H441 line) to filters and dexamethasone (dex) treatment (induction of hemicystosis) with or without magnetoresis. Magnetoresis of unpolarized H441 cells increased transduction at 50 MOI (multiplicity of infection, i.e., transducing units/cell) to 500 MOI in the absence of magnetoresis. Magnetoresis enhanced LV-mediated transduction in mucus layer cells by 20.3-fold. In dexamethasone-induced hemicystosis, LV-mediated transduction efficiency decreased over time. In dome-forming cells, dexamethasone treatment increased zonula occludens-1 (ZO-1) localization at cell borders. Under these experimental conditions, magnetofection significantly increased LV transduction by 5.3-fold. Together, these results suggest that magnetofection can enhance LV-mediated gene transfer to airway epithelial cells in the presence of extracellular (sputum) and cellular (tight junction) barriers, representing a CF-like situation.
H441 cells grown in the presence of 50 nM dexamethasone develop fluid-filled hemicysts, called "domes," that begin to appear from the third day of treatment (Figure 1a). The transduction efficiency of LVs was determined in H441 cultures induced with dexamethasone that were developing domes. In preliminary experiments, the researchers used an MOI of 50 for untreated cells and no ∆NFGR expression was detected. Therefore, transductions were performed at a higher virion-to-cell ratio (i.e., 2000 MOI). With increasing duration of dexamethasone treatment, H441 gradually became more resistant to infection, even at higher MOI of 2000 by using LV–∆NGFR (a lentivirus encoding for nerve growth factor receptor) (Figure 1b). To confirm whether a higher degree of tight junction organization was a feature of dexamethasone-treated H441, the researchers studied transepithelial resistance (TER) and ZO-1 localization in polarized H441 cultures. Figure 1c shows the increase in TER with dexamethasone incubation time, up to 6 days, while the increase in TER without dexamethasone treatment was significantly less pronounced. In H441 cells cultured in the absence of dexamethasone, ZO-1 showed discontinuous junctional staining, not present at every intercellular junction (Figure 1d), whereas its staining was stronger in dexamethasone-treated cells, present at all intercellular boundaries (Figure 1d).
Figure 1. Effect of dexamethasone treatment on dome formation, transepithelial resistance (TER), zonula occludens-1 (ZO-1) organization, and efficiency of LV transduction. (Castellani S, et al., 2016)
Customer Reviews
Fast Shipping
The virus arrived in perfect condition with detailed protocols. We were able to start experiments immediately—no need for additional amplification.
Write a Review